Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Bluebird’s Fast Lyfgenia Launch Was A Year And A Half In The Making; Medicaid Talks Continuing
Zynteglo Build Gives Firm A Leg Up In Sickle Cell Disease
Jan 22 2024
•
By
Mandy Jackson
Bluebird's sickle cell gene therapy Lyfgenia launched in January • Source: Shutterstock
More from Geography
More from J.P. Morgan